3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Hodgkin Disease
24
Lymphoma
18
Testicular Neoplasms
4
Teratoma
3
Recurrence
3
Neoplasms
3
Lymphoma, Large B-Cell, Diffuse
3
HIV Infections
3
Vulvar Neoplasms
2
Testicular Germ Cell Tumor
2
Seminoma
2
Neoplasms, Germ Cell and Embryonal
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Follicular
2
Head and Neck Neoplasms
2
Endodermal Sinus Tumor
2
Dendritic Cell Sarcoma, Interdigitating
2
Carcinoma, Embryonal
2
Burkitt Lymphoma
2
Acquired Immunodeficiency Syndrome
2
Waldenstrom Macroglobulinemia
1
Ulcer
1
Squamous Cell Carcinoma of Head and Neck
1
Sertoli-Leydig Cell Tumor
1
Sarcoma, Kaposi
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Processes
1
Ovarian gynandroblastoma
1
Interventions
nilotinib
1
Everolimus
1
Electrochemotherapy
1
Bleomycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Neoplastic Processes
×
Bleomycin
×
Clear all
NCT03040180
2019-01-25
nECT
Zealand University Hospital
Phase 2
Unknown
40 enrolled